The Cost Effectiveness of Lowering Cholesterol in Individual Patients

Abstract

Summaries for Patients16 May 2000The Cost Effectiveness of Lowering Cholesterol in Individual PatientsSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-132-10-200005160-00036 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?National guidelines recommend cholesterol-lowering treatment on the basis of an individual patient's cholesterol levels and risk factors for heart disease. However, using drugs to lower cholesterol levels is expensive. It is unclear for which types of patients this cost is worth the benefit. Statins are the major type of medicines used to lower cholesterol levels.Why did the researchers do this particular study?The researchers wanted to find out how the costs and benefits of cholesterol-lowering therapy vary with individual patient risk factors, including age, sex, smoking, blood ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Cost-Effectiveness of Cholesterol-Lowering Therapies according to Selected Patient Characteristics”. It is in the 16 May 2000 issue of Annals of Internal Medicine (volume 132, pages 769-779). The authors are L.A. Prosser, A.A. Stinnett, P.A. Goldman, L.W. Williams, M.G.M. Hunink, L. Goldman, and M.C. Weinstein.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCost-Effectiveness of Cholesterol-Lowering Therapies according to Selected Patient Characteristics Lisa A. Prosser , Aaron A. Stinnett , Paula A. Goldman , Lawrence W. Williams , Maria G.M. Hunink , Lee Goldman , and Milton C. Weinstein Metrics 16 May 2000Volume 132, Issue 10Page: 769KeywordsCholesterolDrugsHypercholesterolemiaLow density lipoproteinMedical risk factorsMyocardial infarctionQuality adjusted life yearsSimulation and modelingStatinsTreatment guidelines ePublished: 15 August 2000 Issue Published: 16 May 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.Loading ...